Umar Afridi
CEO

Foundation Health offers a Direct Care platform that provides affordable access to GLP-1 prescriptions through a streamlined process that includes virtual consultations and home delivery. The platform integrates telehealth and pharmacy services via APIs, enabling health plans and insurers to enhance medication management and improve patient access to essential treatments.
Raised to date
$6MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.





Many individuals lack affordable and convenient access to prescriptions for glucagon-like peptide-1 (GLP-1) receptor agonists, medications used in the treatment of diabetes and weight management. Traditional healthcare models often involve time-consuming in-person consultations and pharmacy visits, creating barriers to timely and consistent access to these medications.
Foundation Health offers a Direct Care platform that streamlines access to GLP-1 prescriptions through a combination of telehealth and virtual pharmacy services. The platform provides patients with affordable access to GLP-1 medications via virtual consultations, asynchronous questionnaires, and home delivery. By integrating telehealth and pharmacy services through APIs, Foundation Health enables health plans, insurers, and pharmaceutical manufacturers to enhance medication management, improve patient access, and create engaging consumer experiences. The platform also offers white-labeled solutions, allowing partners to maintain their brand identity throughout the patient journey.
The primary target audience includes health plans, insurers, pharmaceutical manufacturers, and healthcare providers seeking to improve medication access and management for their patients or members.